U.S. FDA approved Avion Pharmaceuticals, LLC’s Balcoltra (ethinyl estradiol/levonorgestrel and ferrous bisglycinate) Tablets
U.S. FDA has given green signal to Avion Pharmaceuticals, LLC’s Balcotra Tablets
U.S. FDA (Food and Drug Administration) recently gave green signal to Avion Pharmaceuticals, LLC’s Balcotra (ethinyl estradiol/levonorgestrel and ferrous bisglycinate) Tablets
Company: Avion Pharmaceuticals, LLC
Brand Name: Balcotra
Treatment for: Birth Control
Dosage Form: Tablets
Generic name: ethinyl estradiol/levonorgestrel and ferrous bisglycinate
General information about Balcoltra
Balcotra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets) is a progestin/estrogen combination oral contraceptive (COC) indicated for use by females of reproductive potential to prevent pregnancy.
Balcoltra is the only branded contraceptive that combines levonorgestrel 0.1mg and ethinyl estradiol 20mcg with ferrous bisglycinate 36.5mg. Combination oral contraceptives lower the risk of becoming pregnant primarily by suppressing ovulation. Other possible mechanisms may include cervical mucus changes that inhibit sperm penetration and endometrial changes that reduce the likelihood of implantation.
